Hisun Pharmaceutical: Net profit of 541 million yuan in 2025, down 10.06% year-on-year

2026-04-10 15:46:23

Hizheng Pharmaceutical announced that in 2025, operating revenue will be 10.55 billion yuan, a year-on-year increase of 2.03%. Net profit attributable to shareholders of the listed company is 541 million yuan, a decrease of 10.06% year-on-year. The company plans to distribute a cash dividend of 0.21 yuan (tax included) per share to all shareholders, with a total cash dividend of 243 million yuan (tax included).

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.